Population Health Management[JOURNAL]

In a nationally representative population-based study of US adults, the authors sought to examine the association between body mass index (BMI) and all-cause and cardiovascular disease (CVD) mortality in a nationally rep... In a nationally representative population-based study of US adults, the authors sought to examine the association between body mass index (BMI) and all-cause and cardiovascular disease (CVD) mortality in a nationally representative sample of adults with and without atherosclerotic cardiovascular disease (ASCVD), and further stratified by age, sex, and race/ethnicity. The study used data from 2006 to 2015 National Health Interview Survey and categorized participants into the following BMI categories: normal weight (20-24.9), overweight (25-29.9), obesity class 1 (30-34.9), obesity class 2 (35-39.9), and obesity class 3 (≥40 kg/m). Multivariable Cox proportional hazards models were used to assess the risk of all-cause and CVD mortality across successively increasing BMI categories overall, and by sociodemographic subgroups. A total of 210,923 individuals were included in the final analysis. In the population without ASCVD, the risk of all-cause and CVD mortality was lower in overweight and higher in obesity classes 2 and 3, compared with normal weight, with the highest risk observed in the young adult (age 18-39) population. Elderly adults (65 and above) and populations with ASCVD exhibited a BMI-mortality paradox. In addition, Hispanic individuals did not show a relationship between BMI and mortality compared with non-Hispanic White and Black adults. In conclusion, being overweight was associated with decreased risk, whereas obesity class 3 was consistently associated with increased risk of all-cause and CVD mortality in adults without ASCVD, particularly young adults. BMI-mortality paradox was noted in ASCVD, elderly, and non-Hispanic adults.

Get PDF PubMed ↗

Emerging Health System, Provider, and Payer Opportunities in Population Health Delivery.

Eldridge JE, Berkowitz SA

Popul Health Manag · 2023 Aug · PMID 37590067 · Publisher ↗

Abstract loading — click title to view on PubMed.

Get PDF PubMed ↗

Accelerating Success in Value-Based Care and Population Health: Learnings from a High-Performing Physician Organization.

Sud RN

Popul Health Manag · 2023 Aug · PMID 37590066 · Publisher ↗

Abstract loading — click title to view on PubMed.

Get PDF PubMed ↗

The Future of Population Health.

Hayatdavoudi AB

Popul Health Manag · 2023 Aug · PMID 37590065 · Publisher ↗

Abstract loading — click title to view on PubMed.

Get PDF PubMed ↗

Lessons Learned from the Camden Coalition's Work with High Needs, High Complexity Patients.

Brenner J

Popul Health Manag · 2023 Aug · PMID 37590064 · Publisher ↗

The Camden Coalition of Healthcare Providers built a nationally recognized model of intensive care coordination for high needs, high complexity patients. The model was tested using a randomized controlled trial, which sh... The Camden Coalition of Healthcare Providers built a nationally recognized model of intensive care coordination for high needs, high complexity patients. The model was tested using a randomized controlled trial, which showed no impact on hospital and emergency room utilization. This was a surprising result at the time. The negative results may have been due to several factors including untreated and unresolved early life trauma, lack of access to appropriately trained local services, and incorrect diagnosis and treatments within the health care field. Integration of high-quality primary care services within the mental health and social service field may be a more effective solution than coordination between services.

Get PDF PubMed ↗

Future Trends to Watch for Value-Based Care.

Angelo M, Port J

Popul Health Manag · 2023 Aug · PMID 37590063 · Publisher ↗

Abstract loading — click title to view on PubMed.

Get PDF PubMed ↗

Health Care Organizations and Digital Startups: Two Cultures.

Jubelt LE

Popul Health Manag · 2023 Aug · PMID 37590062 · Publisher ↗

Abstract loading — click title to view on PubMed.

Get PDF PubMed ↗

Commentary Contributors.

Popul Health Manag · 2023 Aug · PMID 37590061 · Publisher ↗

Abstract loading — click title to view on PubMed.

Get PDF PubMed ↗

Gun Violence Prevention Policies Are Not Political: They Are Just Part of Good Public Health.

Stevens J, Cornell E, Ng L … +1 more , Sathya C

Popul Health Manag · 2023 Aug · PMID 37590060 · Publisher ↗

Abstract loading — click title to view on PubMed.

Get PDF PubMed ↗

Opportunities and Challenges in Screening for Colorectal Cancer.

Miller Wilson LA, Browne S, Barnes J … +4 more , Hoyek NE, Helmueller L, Joao Janeiro M, Wendt B

Popul Health Manag · 2023 Aug · PMID 37498933 · Full text

Colorectal cancer (CRC) is a leading cause of mortality in the United States. Outcomes are greatly improved if CRC is detected early; hence, screening is currently recommended for adults aged 45 years and older at averag... Colorectal cancer (CRC) is a leading cause of mortality in the United States. Outcomes are greatly improved if CRC is detected early; hence, screening is currently recommended for adults aged 45 years and older at average risk for the disease. Despite this recommendation and the availability of accurate screening tests, the CRC screening rates are below those recommended. The goal of this study was to identify temporal trends (from 2015 to 2019) in CRC screening rates and the utilization of screening tests recommended for CRC detection among average-risk individuals within the St Elizabeth Healthcare system in Kentucky, United States. The primary population of interest was patients aged 50-75 years (the CRC screening was recommended for this age group at the time of the study). Deidentified data were sourced from patients' electronic health records, and the results showed that screening rates increased significantly from 26% in 2015 to 49% in 2019 (<0.0001). The incidence of any screening test also increased significantly from 2015 to 2019, for those who were due for screening ( < 0.05) and for the entire cohort ( < 0.1). The use of multitarget stool DNA (mt-sDNA) increased 40-fold over the study timeframe ( < 0.05). These study results confirm that CRC screening rates remain suboptimal, although incidence and adherence improved significantly in those aged 50-75 years from 2015 to 2019. The growing adoption and availability of mt-sDNA may be correlated with an increase in overall screening in this average-risk population.

Free PDF PubMed ↗

Population Health Management[JOURNAL]

About